Rutamycin (A272)

A macrolide antibiotic of the oligomycin group, obtained from Streptomyces rutgersensis. It is used in cytochemistry as a tool to inhibit various ATPases and to uncouple oxidative phosphorylation from electron transport and also clinically as an antifungal agent.

Also Known As:

A272; A 272; A-272; RR-32705; RR 32705; RR32705; Oligomycin D; Oligomycin A, 26-demethyl-

Networked: 7 relevant articles (0 outcomes, 1 trials/studies)

Bio-Agent Context: Research Results

Organic Chemicals: 133
- Lactones: 1549
  - Macrolides: 4391
    - Oligomycins: 193
      - Rutamycin: 7

Experts

1.	Edwards, Joanne: 1 article (01/2019)
2.	Horgan, Paul G: 1 article (01/2019)
3.	Horstman, Sheryl L: 1 article (01/2019)
4.	Inthagard, Jitwadee: 1 article (01/2019)
5.	McMillan, Donald C: 1 article (01/2019)
6.	Park, James H: 1 article (01/2019)
7.	Powell, Arfon G M T: 1 article (01/2019)
8.	Roseweir, Antonia K: 1 article (01/2019)
9.	Jabbour, Anissa: 1 article (10/2018)
10.	Kok, Chung Hoow: 1 article (10/2018)

Related Diseases

1.	Malaria 01/01/2012 - "There was a 64% overall drop in annual malaria-positive coma admissions and a 272% overall increase in annual admissions with encephalopathies of undetermined cause over the study period. "
2.	Coma (Comas) 01/01/2012 - "There was a 64% overall drop in annual malaria-positive coma admissions and a 272% overall increase in annual admissions with encephalopathies of undetermined cause over the study period. "
3.	Brain Diseases (Brain Disorder) 01/01/2012 - "There was a 64% overall drop in annual malaria-positive coma admissions and a 272% overall increase in annual admissions with encephalopathies of undetermined cause over the study period. "
4.	Neoplasms (Cancer) 01/01/2019 - "The relationship between SFK expression, inflammatory responses and cancer specific survival (CSS) in stage I-III CRC patients was assessed using immunohistochemistry on a 272 patient discovery cohort and an extended 822 patient validation cohort. "
5.	Glioma (Gliomas) 10/01/2018 - "Additionally, using a 272 primary glioma sample RNA-seq dataset, Co-fuse was able to validate recurrent fusion genes, further demonstrating the power of this analysis tool to identify recurrent fusion genes. "

Related Drugs and Biologics

1.	Tumor Necrosis Factor-alpha (Tumor Necrosis Factor)
2.	RNA (Ribonucleic Acid)
3.	Homocysteine

Related Therapies and Procedures

1.	Aftercare (After-Treatment)